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Introduction {#jah32216-sec-0004}
============

Hypertension is a common chronic disease and a major risk factor for cardiovascular diseases. It can cause heart failure, myocardial infarction, and organ injuries, such as renal, cerebral and myocardial damage, which can significantly harm a person\'s quality of life. Carotid sinus baroreflex is one of the most important neural feedback mechanisms to regulate and maintain stable blood pressure. A study suggested that in patients with hypertension, baroreflex sensitivity (BRS) was decreased significantly, which was associated with the thickness of the baroreceptor vascular wall.[1](#jah32216-bib-0001){ref-type="ref"} Hypertension, hypotension and orthostatic tachycardia may occur in patients with bilateral carotid sinus resection as a result of trauma or local tumor surgery, whereas syncope led by hypotension occurs in patients with hypersensitivity of the carotid sinus.[2](#jah32216-bib-0002){ref-type="ref"}, [3](#jah32216-bib-0003){ref-type="ref"} Thus, the carotid sinus plays important physiological and pathophysiological roles in the regulation of blood pressure.

The carotid sinus baroreceptor is an important part of baroreflex and is dominant in baroreceptors and blood pressure regulation. It can sense the mechanical stretch stimulation of blood vessel walls directly, and its sensitivity is regulated by many factors, mainly from circulation or secreted by cells in the carotid sinus. Prostacyclin, for example, which is released from endothelial cells, can enhance carotid sinus baroreceptor sensitivity by acting on nerve endings instead of changing the vascular tension. In sensory neurons, nitric oxide can be generated and can inhibit carotid sinus baroreceptor sensitivity, although the mechanisms remain unclear.[4](#jah32216-bib-0004){ref-type="ref"}

Gaseous signal molecules with the characteristics of small molecular weight, continuous production and rapid dispersion, can freely pass through a variety of biological membranes. Hydrogen sulfide (H~2~S) was discovered as the third gaseous molecule after nitric oxide and carbon monoxide. H~2~S is generated from the cysteine metabolic pathway catalyzed by cystathionine‐β‐synthase (CBS), cystathionine γ‐lyase (CSE), and 3‐mercaptopyruvate sulfurtransferase, and it has extensive biological effects.[5](#jah32216-bib-0005){ref-type="ref"}, [6](#jah32216-bib-0006){ref-type="ref"}, [7](#jah32216-bib-0007){ref-type="ref"}, [8](#jah32216-bib-0008){ref-type="ref"}, [9](#jah32216-bib-0009){ref-type="ref"} Our group found that gaseous molecules have important roles in regulating local vascular function.[10](#jah32216-bib-0010){ref-type="ref"}, [11](#jah32216-bib-0011){ref-type="ref"} Downregulation of the endogenous H~2~S system is an important mechanism in spontaneously hypertensive rats (SHRs).[12](#jah32216-bib-0012){ref-type="ref"}, [13](#jah32216-bib-0013){ref-type="ref"} Previous studies have indicated that H~2~S was involved in short‐term and long‐term blood pressure regulation, under both physiological and pathological conditions.[12](#jah32216-bib-0012){ref-type="ref"}, [13](#jah32216-bib-0013){ref-type="ref"}, [14](#jah32216-bib-0014){ref-type="ref"}, [15](#jah32216-bib-0015){ref-type="ref"}, [16](#jah32216-bib-0016){ref-type="ref"}

A study revealed that an H~2~S donor facilitated carotid sinus baroreceptor activity in normal rats, and the baroreflex functional curve indicated that carotid sinus baroreceptor sensitivity was enhanced by H~2~S. The effect was concentration dependent,[17](#jah32216-bib-0017){ref-type="ref"} which suggested that H~2~S might be involved in regulation of carotid sinus baroreceptor sensitivity. This gives rise to a series of questions that have yet to be answered: During the development of hypertension, does carotid sinus baroreceptor sensitivity change? Is H~2~S involved in regulating sinus baroreceptor sensitivity? What is the possible specific mechanism?

It is accepted that endogenous regulatory factors can regulate the baroreceptor by affecting receptor nerve terminals directly targeting voltage‐dependent ion channels, such as transient receptor potential cation channel subfamily V member 1 (TRPV1), transient receptor potential cation channel subfamily C member 5 (TRPC5), and acid‐sensing ion channel 2 (ASIC2).[4](#jah32216-bib-0004){ref-type="ref"}, [18](#jah32216-bib-0018){ref-type="ref"}, [19](#jah32216-bib-0019){ref-type="ref"} TRPV1, the first member of the transient receptor potential family to be discovered, is distributed mainly in sensory nerve endings and mediates thermal effect and pain afferent.[20](#jah32216-bib-0020){ref-type="ref"} TRPV1 distribution was found in aortic baroreceptors, and TRPV1 participated in the perception, conduction, and regulation of mechanical stimulation.[21](#jah32216-bib-0021){ref-type="ref"} Studies suggested that TRPV1 mediated H~2~S‐induced neurogenic inflammation[22](#jah32216-bib-0022){ref-type="ref"} and promoted the release of inhibitory neuropeptide.[23](#jah32216-bib-0023){ref-type="ref"}, [24](#jah32216-bib-0024){ref-type="ref"} Nevertheless, it is unclear whether H~2~S regulates carotid sinus baroreceptor sensitivity by activating TRPV1, and the mechanism by which H~2~S affects TRPV1 is unknown.

This study aimed to explore whether H~2~S regulated carotid sinus baroreceptor sensitivity through TRPV1 in the development of hypertension and to examine the possible molecular mechanisms.

Methods {#jah32216-sec-0005}
=======

Animals {#jah32216-sec-0006}
-------

### Animal experiment {#jah32216-sec-0007}

Four‐week‐old male Wistar‐Kyoto (WKY) rats and SHRs were used as experimental animal models. Each type of rats was divided randomly into 3 groups (8 rats in each group): control (0.9% normal saline 4 mL/kg, intraperitoneal injection every day for 8 weeks), hydroxylamine (HA; HA is an inhibitor of CBS; 12.5 mg/kg,[25](#jah32216-bib-0025){ref-type="ref"} intraperitoneal injection every day for 8 weeks), and NaHS (90 μmol/kg, intraperitoneal injection every day for 8 weeks).

### Isolated carotid sinus perfusion experiment {#jah32216-sec-0008}

Overall, 56 WKY rats and 56 SHRs (male, weight 300±10 g) were used in the experiment. SHRs and WKY rats were randomly divided into 7 groups (in total, 14 groups with 8 rats in each group): control (perfusate: Krebs‐Henseleit \[K‐H\] solution for 50 minutes), NaHS (perfusate: K‐H solution for 20 minutes, then change to K‐H solution containing 90 μmol/L NaHS for 30 minutes), HA (perfusate: K‐H solution for 20 minutes, then K‐H solution containing 12.5 mg/L HA for 30 minutes), capsaicin (perfusate: K‐H solution for 20 minutes, then K‐H solution containing capsaicin 1.0 mg/L for 30 minutes), capsazepine (perfusate: K‐H solution for 20 minutes, then K‐H solution containing capsazepine 15 mg/L for 30 minutes), capsaicin plus NaHS (perfusate: K‐H solution containing capsaicin 1.0 mg/L perfused for 20 minutes, then changed to K‐H solution containing NaHS 90 μmol/L for 30 minutes), and capsazepine plus NaHS (perfusate: K‐H solution containing capsazepine 15 mg/L perfused for 20 minutes, then changed to K‐H solution containing NaHS 90 μmol/L for 30 minutes).

### Incubation of carotid sinus {#jah32216-sec-0009}

In total, 24 WKY rats (male, weight 300±10 g) were randomly divided into 3 groups (8 rats in each group): control (carotid sinus tissues were incubated with 95% O~2~ to 5% CO~2~ K‐H solution for 6 hours), HA (carotid sinus tissues were incubated with 95% O~2~ to 5% CO~2~ K‐H solution containing HA 12.5 mg/L for 6 hours), and NaHS (carotid sinus tissues were incubated with 95% O~2~ to 5% CO~2~ K‐H solution containing NaHS 90 μmol/L for 6 hours).

All experimental animals were purchased from Beijing Vital River Laboratory Animal Technology Co, Ltd (license number SCXK 2012‐0001). All rats were raised in the Animal Center of Peking University First Hospital. During the experiment, all rats were given normal diets at 25°C constant temperature with a circadian rhythm of 12‐hour dark/light. All experimental operations strictly abided by laboratory animal welfare and operational guidelines and were approved by the experimental ethics committee of Peking University First Hospital.

Measurement of Hemodynamic Parameters in Rats {#jah32216-sec-0010}
---------------------------------------------

Rats were anesthetized with 5% urethane (5 mL/kg) by intraperitoneal injection and fixed with the left carotid artery separated. One end of a polyethylene catheter was inserted into the left carotid artery, whereas the other end was connected to a pressure transducer (PT‐100; Chengdu Technology & Market Co Ltd) and biological experimental system (BL‐420S; Chengdu Technology & Market Co Ltd). In this way, the systolic blood pressure (SBP) of rats was recorded.

Detection of H~2~S Concentration in Plasma {#jah32216-sec-0011}
------------------------------------------

Arterial blood was taken and centrifuged at 3000*g* at 4°C for 20 minutes to get plasma. H~2~S concentration was detected by using the sensitive sulfur electrode (PXS‐270; Shanghai Leici). Standard solution, prepared by Na~2~S, and plasma were mixed with equal volume of antioxidants. A sulfur‐sensitive electrode and the reference electrode were immersed at the same time. Results were recorded when the reading was stabilized. H~2~S concentration in plasma was calculated according to the standard curve.[26](#jah32216-bib-0026){ref-type="ref"}

Detection of Carotid Sinus Baroreceptor Sensitivity by Isolated Carotid Sinus Perfusion Technique {#jah32216-sec-0012}
-------------------------------------------------------------------------------------------------

The rats were anesthetized with 25% urethane (5 mL/kg) by intraperitoneal injection. Carotid sinus area of rats was fully exposed with endotracheal intubation. Under the microscope, the bilateral aortic nerves, cervical sympathetic nerves, recurrent laryngeal nerves, and right carotid sinus nerve were isolated and cut off. The left carotid sinus was isolated, and the internal carotid artery, superior thyroid artery, ascending pharyngeal artery, and occipital artery were ligated, leaving the left common carotid artery as the inflow tract and the left external carotid artery as the outflow tract. The inflow tract was connected to the pressure transducer, which monitored the intrasinus pressure (ISP) in the perfusion process. The distal end of the left femoral artery was ligated, and the proximal end was inserted by a polyethylene catheter, which was connected to a pressure transducer to record mean arterial pressure (MAP). A biological experimental system (BL‐420S) was used for recording ISP and MAP. The functional curve of the carotid baroreceptor (FCCB) was made with ISP as abscissa and MAP as ordinate. The following parameters were detected: threshold pressure (TP; the ISP value when MAP dropped 5.025 mm Hg reflectively), equilibrium pressure (EP; the pressure value when MAP is equal to ISP), saturation pressure (SP; the ISP value when MAP showed no further decrease with the increase of ISP), operating range (OR; calculated as SP minus TP), peak slope (PS; maximum slope of the FCCB), and reflex decrease (RD; the maximum decrease of MAP). When the carotid sinus baroreceptor sensitivity was enhanced, the FCCB moved to the left and downward; in contrast, with the reduction of carotid sinus baroreceptor sensitivity, the FCCB moved to the right and upward.[17](#jah32216-bib-0017){ref-type="ref"}

Detection of TRPV1 mRNA Level by Quantitative Real‐Time Polymerase Chain Reaction {#jah32216-sec-0013}
---------------------------------------------------------------------------------

TRPV1 mRNA level in incubated carotid sinus tissue was detected by quantitative real‐time polymerase chain reaction (PCR). Trizol reagent was used to extract total RNA. Oligodt primer, 2.5 mmol/L dNTP, and M‐MLV reverse transcriptase were used for reverse transcription. Primers and probes were synthesized by Sangon Biotech Company: for TRPV1, forward, 5′‐TGTTTGTGGACAGCTACAGTGAGA‐3′, reverse, 5′‐AGTACCACAGACACCAGCATGAA‐3′, Taqman probe, 5′‐ ACTTTTCTTTGTACAGTCGCT‐3′; for β‐actin, forward, 5′‐ACCCGCGAGTACAACCTTCTT‐3′, reverse, 5′‐TATCGTCATCCATGGCGAACT‐3′, Taqman probe, 5′‐CCTCCGTCGCCGGTCCACAC‐3′. The PCR mixture contained 2.5 μL of 10× PCR buffer, 2 μL of 2.5 mmol/L each dNTP, 2.5 U *Taq* DNA polymerase, 0.5 μL of 6‐carboxy‐X‐rhodamine, 7.5 pmol of each forward and reverse primer, 5 pmol *Taq* Man probe, and 2 μL of cDNA template or standard DNA in a total volume of 25 μL. Samples and standard DNA were detected in duplicate. Quantitative real‐time PCR was performed on an ABI PRISM 7300 instrument (Applied Biosystems), and the condition was set to predenaturing at 95°C for 5 minutes, and then 95°C for 15 seconds and 60°C for 1 minute for 40 cycles.[27](#jah32216-bib-0027){ref-type="ref"}

Detection of CBS, TRPV1, CSE, ASIC2, and TRPC5 Protein Expression by Western Blotting {#jah32216-sec-0014}
-------------------------------------------------------------------------------------

Carotid sinus and common carotid artery samples were homogenized in 1× tissue lysate and centrifuged at 13 000*g* for 20 minutes at 4°C to get supernatant. Protein content was determined according to the Bradford method, with bovine serum albumin used as a standard. Protein samples were mixed with 2× loading buffer containing 5% β‐mercaptoethanol and boiled for 5 minutes. Equal amounts of protein were added to the polyacrylamide gel for electrophoresis and transferred onto a nitrocellulose membrane. Nonspecific binding was blocked by incubation in milk for 1 hour at room temperature. Primary antibodies CBS, TRPV1, CSE, ASIC2, TRPC5, GAPDH, and β‐actin were added and incubated at 4°C overnight. After wash with Tris‐buffered saline with 1% Tween, secondary antibodies were added and incubated at room temperature for 1 hour. A chemiluminescence detection kit and AlphaImager gel imaging system (ProteinSimple) were used to enhance immunoreactions and to analyze the density of protein bands, respectively.

Detection of S‐Sulfhydration Modification Level of TRPV1 {#jah32216-sec-0015}
--------------------------------------------------------

After 50‐minute‐perfusion experiment, the carotid sinuses of rats were homogenized in 1× tissue lysate and centrifuged at 13 000*g* at 4°C for 20 minutes. The supernatant was taken and divided into 2 parts: one part for total protein and another part for S‐sulfhydryl protein extraction. Next, 2.5% SDS and 20 mmol/L S‐methyl methanethiosulfonate were added and incubated with gentle shaking at 50°C for 20 minutes. Acetone, precooled at −20°C, was added to the mixture with volume ratio of 4:1, precipitated at −20°C for 2 hours, and centrifuged at 12 000*g* at 4°C for 10 minutes to get precipitate. After being resuspended in 1 mL 1× tissue lysate and incubated with Z‐Link iodoacetyl‐PEG2 biotin, avoiding light at 4°C for 12 hours, Ultra Link Immobilized NeutrAvidin (Thermo Scientific) was added and incubated with shaking at 4°C for 4 hours. The precipitate was retrieved with centrifugation and washed with PBS (0.01 mmol/L). The samples were mixed with loading buffer without β‐mercaptoethanol and centrifuged at 5000*g* for 10 minutes to get supernatant containing S‐sulfhydryl protein. Finally, western blotting was used to detect the S‐sulfhydration modification level of TRPV1.

Statistical Analysis {#jah32216-sec-0016}
--------------------

SPSS17.0 software was used for statistical analysis. All results are expressed as mean±SE. For normally distributed data, comparisons among groups were analyzed by 1‐way ANOVA. When the overall difference showed significance, Bonferroni analysis was performed for comparison of the difference between the 2 groups. For nonnormally distributed data, the Kruskal--Wallis rank sum test was used for multiple comparisons. For outcomes measured serially of FCCB sensitivity, repeated‐measures analysis was used to test for overall differences before the tests performed at each ISP level. *P*\<0.05 was considered statistically significant.

Results {#jah32216-sec-0017}
=======

The Endogenous CBS/H~2~S Pathway Was Downregulated in Carotid Sinus of SHRs {#jah32216-sec-0018}
---------------------------------------------------------------------------

To detect the changes in endogenous H~2~S concentration in rats, we used a sensitive sulfur electrode and western blotting to detect H~2~S concentration in plasma and CBS protein expressions in the carotid sinus and the common carotid artery. Compared with WKY rats, SBP in SHRs was increased (Figure [1](#jah32216-fig-0001){ref-type="fig"}A), H~2~S concentration in the plasma of SHRs decreased significantly (Figure [1](#jah32216-fig-0001){ref-type="fig"}B), CBS expression in carotid sinus was clearly reduced (Figure [1](#jah32216-fig-0001){ref-type="fig"}C), and no significant changes in the common carotid artery were noted (Figure [1](#jah32216-fig-0001){ref-type="fig"}D).

![Systolic blood pressure, plasma H~2~S concentration, and CBS and CSE protein expressions in SHRs and WKY rats. A, SBP in rats. B, H~2~S concentration in plasma. C, CBS protein expression in carotid sinus. D, CBS protein expression in common carotid arteries. E, CSE protein expression in carotid sinus. Mean±SE, n=8. \**P*\<0.05. CBS indicates cystathionine‐β‐synthase; CSE, cystathionine γ‐lyase; HA, hydroxylamine; SBP, systolic blood pressure; SHR, spontaneously hypertensive rat; WKY, Wistar‐Kyoto rat.](JAH3-6-e004971-g001){#jah32216-fig-0001}

H~2~S Reduced Blood Pressure of Hypertensive Rats {#jah32216-sec-0019}
-------------------------------------------------

We used H~2~S donor NaHS or CBS inhibitor HA to increase or decrease H~2~S content in rats. In SHRs, with H~2~S supplement, H~2~S concentration in plasma increased and SBP decreased significantly, with no change in CBS protein expression in the carotid sinus. After the use of HA, CBS protein expression was significantly reduced in the carotid sinus of SHRs, which led to a decrease in H~2~S concentration in plasma and a further increase in SBP (Figure [1](#jah32216-fig-0001){ref-type="fig"}).

After giving H~2~S donor NaHS, H~2~S concentration in plasma, the expression of CBS in the carotid sinus, and SBP of WKY rats did not change. In contrast, with the administration of HA, CBS expression in the carotid sinus decreased, followed by a reduction in H~2~S concentration in plasma, which finally resulted in an increase in SBP in WKY rats. However, CBS protein expression in common carotid arteries did not differ among different groups, nor did CSE protein expression in carotid sinus tissues (Figure [1](#jah32216-fig-0001){ref-type="fig"}D and [1](#jah32216-fig-0001){ref-type="fig"}E).

Carotid Sinus Baroreceptor Sensitivity Was Reduced in Hypertensive Rats {#jah32216-sec-0020}
-----------------------------------------------------------------------

We used the isolated carotid sinus perfusion technique to detect carotid sinus baroreceptor sensitivity. The FCCB was plotted with ISP and MAP recorded and related parameters including TP, EP, SP, PS, OR and RD that were subsequently analyzed. Results showed that in comparison to WKY rats, carotid sinus baroreceptor sensitivity in SHRs was reduced. This was demonstrated by the fact that the FCCB moved to the right and upward (Figure [2](#jah32216-fig-0002){ref-type="fig"}) and TP and EP were increased, whereas OR, RD, and PS were decreased significantly (Table [1](#jah32216-tbl-0001){ref-type="table-wrap"}).

###### 

Effects of H~2~S on the Functional Parameters of Carotid Sinus Baroreceptor in Rats

  Groups        TP (mm Hg)                                           EP (mm Hg)                                           SP (mm Hg)                                           OR (mm Hg)                                           PS (mm Hg/mm Hg)                                   RD (mm Hg)
  ------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- -------------------------------------------------- ---------------------------------------------------
  WKY control   134.90±1.77                                          118.19±0.22                                          234.57±1.07                                          99.67±1.08                                           0.28±0.01                                          31.78±0.42
  WKY+NaHS      115.11±0.86[a](#jah32216-note-0002){ref-type="fn"}   115.39±0.47[a](#jah32216-note-0002){ref-type="fn"}   221.64±1.00[a](#jah32216-note-0002){ref-type="fn"}   106.53±0.92[a](#jah32216-note-0002){ref-type="fn"}   0.30±0.01                                          39.57±0.15[a](#jah32216-note-0002){ref-type="fn"}
  WKY+HA        143.33±1.51[a](#jah32216-note-0002){ref-type="fn"}   119.69±0.25[a](#jah32216-note-0002){ref-type="fn"}   238.86±1.42                                          95.53±1.26[a](#jah32216-note-0002){ref-type="fn"}    0.22±0.01[a](#jah32216-note-0002){ref-type="fn"}   25.41±0.66[a](#jah32216-note-0002){ref-type="fn"}
  SHR control   148.66±1.84[a](#jah32216-note-0002){ref-type="fn"}   168.66±0.86[a](#jah32216-note-0002){ref-type="fn"}   224.55±1.25[a](#jah32216-note-0002){ref-type="fn"}   75.89±1.99[a](#jah32216-note-0002){ref-type="fn"}    0.22±0.01[a](#jah32216-note-0002){ref-type="fn"}   23.47±0.65[a](#jah32216-note-0002){ref-type="fn"}
  SHR+NaHS      136.45±1.01[b](#jah32216-note-0003){ref-type="fn"}   165.94±0.40[b](#jah32216-note-0003){ref-type="fn"}   217.56±0.47[b](#jah32216-note-0003){ref-type="fn"}   81.11±0.92                                           0.33±0.01[b](#jah32216-note-0003){ref-type="fn"}   31.16±0.53[b](#jah32216-note-0003){ref-type="fn"}
  SHR+HA        163.80±1.42[b](#jah32216-note-0003){ref-type="fn"}   172.33±0.48[b](#jah32216-note-0003){ref-type="fn"}   230.87±1.30[b](#jah32216-note-0003){ref-type="fn"}   67.07±1.83[b](#jah32216-note-0003){ref-type="fn"}    0.16±0.01[b](#jah32216-note-0003){ref-type="fn"}   18.32±0.20[b](#jah32216-note-0003){ref-type="fn"}

EP indicates equilibrium pressure; HA, hydroxylamine; K‐H, Krebs‐Henseleit; OR, operating range; PS, peak slope; RD, reflex decrease; SHR, spontaneously hypertensive rat; SP, saturation pressure; TP, threshold pressure; WKY, Wistar‐Kyoto rat.

*P*\<0.05 vs WKY control.

*P*\<0.05 vs SHR control.

John Wiley & Sons, Ltd

H~2~S Facilitated Carotid Sinus Baroreflex of Rats {#jah32216-sec-0021}
--------------------------------------------------

In the carotid sinus perfused rat model, we intervened with the H~2~S content of carotid sinus by adding NaHS or HA into the perfusate. With the supplement of H~2~S, carotid sinus baroreceptor sensitivity in SHRs was enhanced; the FCCB shifted to the left and downward (Figure [2](#jah32216-fig-0002){ref-type="fig"}), TP, EP and SP were reduced, whereas PS and RD were increased significantly (Table [1](#jah32216-tbl-0001){ref-type="table-wrap"}). After inhibiting the generation of H~2~S, carotid sinus baroreceptor sensitivity in SHRs was reduced; the FCCB shifted to the right and upward (Figure [2](#jah32216-fig-0002){ref-type="fig"}), TP, EP and SP were increased, whereas OR, RD, and PS were decreased significantly (Table [1](#jah32216-tbl-0001){ref-type="table-wrap"}).

![Effects of H~2~S on carotid sinus baroreceptor sensitivity in rats (mean±SE, n=8). When the carotid sinus baroreceptor sensitivity was enhanced, the FCCB moved to the left and downward; in contrast, with the reduction of carotid sinus baroreceptor sensitivity, the FCCB moved to the right and upward. \**P*\<0.05 vs WKY control group, ^\#^ *P*\<0.05 vs SHR control group. FCCB indicates functional curve of carotid baroreceptor; HA, hydroxylamine; ISP, intrasinus pressure; MAP, mean arterial pressure; SHR, spontaneously hypertensive rat; WKY, Wistar‐Kyoto rats.](JAH3-6-e004971-g002){#jah32216-fig-0002}

After administration of NaHS, carotid sinus baroreceptor sensitivity in WKY rats was enhanced; the FCCB shifted to the left and downward (Figure [2](#jah32216-fig-0002){ref-type="fig"}), TP, EP and SP decreased noticeably, whereas OR and RD were increased (Table [1](#jah32216-tbl-0001){ref-type="table-wrap"}). With the inhibition of H~2~S generation, carotid sinus baroreceptor sensitivity in WKY rats was reduced; the FCCB shifted to the right and upward, TP and EP were increased noticeably, whereas OR, RD, and PS were clearly decreased (Table [1](#jah32216-tbl-0001){ref-type="table-wrap"}).

TRPV1 Was Involved in H~2~S‐induced Enhancement of Carotid Sinus Baroreflex {#jah32216-sec-0022}
---------------------------------------------------------------------------

To test whether TRPV1 was involved in H~2~S‐induced enhancement of carotid sinus baroreflex, we added TRPV1 agonist capsaicin or antagonist capsazepine into perfusate and incubated with low‐speed perfusion for 20 minutes before it was perfused with K‐H solution containing NaHS. Results showed that with the activation of TRPV1, carotid sinus baroreceptor sensitivity in SHRs was further enhanced; the FCCB moved to the left and downward (Figure [3](#jah32216-fig-0003){ref-type="fig"}), TP, EP, and SP were decreased, whereas OR, RD, and PS were increased significantly (Table [2](#jah32216-tbl-0002){ref-type="table-wrap"}). After we inhibited TRPV1 activity, carotid sinus baroreceptor sensitivity in SHRs was inhibited; the FCCB moved to the right and upward (Figure [3](#jah32216-fig-0003){ref-type="fig"}), TP, EP, and SP were increased, whereas OR, RD, and PS were decreased significantly (Table [2](#jah32216-tbl-0002){ref-type="table-wrap"}).

![TRPV1 (transient receptor potential cation channel subfamily V member 1) mediated the regulation of H~2~S in carotid sinus baroreceptor sensitivity (mean±SE, n=8). The functional curve of the carotid baroreceptor shifted to the left and downward with carotid sinus baroreceptor sensitivity being enhanced; however, it shifted to the right and upward when carotid sinus baroreceptor sensitivity was reduced. \**P*\<0.05 vs WKY+NaHS group, ^†^ *P*\<0.05 vs SHR+NaHS group. ISP indicates intrasinus pressure; MAP, mean arterial pressure; SHR, spontaneously hypertensive rat; WKY, Wistar‐Kyoto rat.](JAH3-6-e004971-g003){#jah32216-fig-0003}

###### 

The Role of TRPV1 in the Regulation of Carotid Sinus Baroreceptor by H~2~S

  Groups                 TP (mm Hg)                                           EP (mm Hg)                                           SP (mm Hg)                                           OR (mm Hg)                                           PS (mm Hg/mm Hg)                                   RD (mm Hg)
  ---------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------- -------------------------------------------------- ---------------------------------------------------
  WKY+NaHS               115.11±0.86                                          115.39±0.47                                          221.64±1.00                                          106.53±0.92                                          0.30±0.01                                          39.57±0.15
  WKY+capsaicin+NaHS     100.04±0.76[a](#jah32216-note-0006){ref-type="fn"}   112.70±0.44[a](#jah32216-note-0006){ref-type="fn"}   212.32±0.70[a](#jah32216-note-0006){ref-type="fn"}   112.28±0.89[a](#jah32216-note-0006){ref-type="fn"}   0.32±0.01                                          47.28±0.64[a](#jah32216-note-0006){ref-type="fn"}
  WKY+capsazepine+NaHS   126.64±1.66[a](#jah32216-note-0006){ref-type="fn"}   117.50±0.26[a](#jah32216-note-0006){ref-type="fn"}   227.56±1.05[a](#jah32216-note-0006){ref-type="fn"}   100.92±1.53[a](#jah32216-note-0006){ref-type="fn"}   0.28±0.01[a](#jah32216-note-0006){ref-type="fn"}   33.51±0.38[a](#jah32216-note-0006){ref-type="fn"}
  SHR+NaHS               136.45±1.01                                          165.94±0.40                                          217.56±0.47                                          81.11±0.92                                           0.33±0.01                                          31.16±0.53
  SHR+capsaicin+NaHS     110.55±0.54[b](#jah32216-note-0007){ref-type="fn"}   155.82±0.45[b](#jah32216-note-0007){ref-type="fn"}   195.88±0.78[b](#jah32216-note-0007){ref-type="fn"}   85.33±0.93[b](#jah32216-note-0007){ref-type="fn"}    0.40±0.01[b](#jah32216-note-0007){ref-type="fn"}   37.66±0.18[b](#jah32216-note-0007){ref-type="fn"}
  SHR+capsazepine+NaHS   147.52±0.69[b](#jah32216-note-0007){ref-type="fn"}   168.74±0.30[b](#jah32216-note-0007){ref-type="fn"}   220.98±0.88[b](#jah32216-note-0007){ref-type="fn"}   73.46±0.98[b](#jah32216-note-0007){ref-type="fn"}    0.23±0.01[b](#jah32216-note-0007){ref-type="fn"}   25.83±0.27[b](#jah32216-note-0007){ref-type="fn"}

EP indicates equilibrium pressure; K‐H, Krebs‐Henseleit; OR, operating range; PS, peak slope; RD, reflex decrease; SHR, spontaneously hypertensive rat; SP, saturation pressure; TP, threshold pressure; WKY, Wistar‐Kyoto rat.

*P*\<0.05 vs WKY+NaHS.

*P*\<0.05 vs SHR+NaHS.

John Wiley & Sons, Ltd

With activation of TRPV1, carotid sinus baroreceptor sensitivity in WKY rats was further enhanced; the FCCB moved to the left and downward (Figure [3](#jah32216-fig-0003){ref-type="fig"}), TP, EP, and SP were decreased, whereas OR and RD were increased significantly (Table [2](#jah32216-tbl-0002){ref-type="table-wrap"}). After being pretreated with capsazepine, carotid sinus baroreceptor sensitivity in WKY rats was reduced; the FCCB moved to the right and upward (Figure [3](#jah32216-fig-0003){ref-type="fig"}), TP, EP, and SP were increased, whereas OR, RD, and PS were decreased significantly (Table [2](#jah32216-tbl-0002){ref-type="table-wrap"}).

Carotid sinus baroreceptor sensitivity in WKY rats and SHRs was enhanced by capsaicin, and the FCCB moved to the left and downward. Alternatively, with the administration of capsazepine, the sensitivity of carotid sinus baroreceptor in WKY rats and SHRs was weakened, and the FCCB shifted to the right and upward (Figure [4](#jah32216-fig-0004){ref-type="fig"}).

![The regulatory effects of TRPV1 (transient receptor potential cation channel subfamily V member 1) on carotid sinus baroreceptor sensitivity (mean±SE, n=8). The functional curve of carotid baroreceptor shifted to the left and downward with carotid sinus baroreceptor sensitivity enhancement. Otherwise, it moved to the right and upward when carotid sinus baroreceptor sensitivity was reduced. \**P*\<0.05 vs WKY control group, ^\#^ *P*\<0.05 vs SHR control group. ISP indicates intrasinus pressure; MAP, mean arterial pressure; SHR, spontaneously hypertensive rat; WKY, Wistar‐Kyoto rat.](JAH3-6-e004971-g004){#jah32216-fig-0004}

TRPV1 mRNA Level Was Decreased by Inhibition of H~2~S Generation {#jah32216-sec-0023}
----------------------------------------------------------------

Real‐time PCR was used to detect TRPV1 mRNA levels in carotid sinus tissues of WKY rats after incubation with K‐H solution containing CBS inhibitor or H~2~S donor. TRPV1 mRNA level in carotid sinus was decreased after treatment with HA but did not change after treatment with the H~2~S donor (Figure [5](#jah32216-fig-0005){ref-type="fig"}A).

![The TRPV1 mRNA level and protein expressions of TRPV1, ASIC2, and TRPC5 in the carotid sinus of rats. A, TRPV1 mRNA level in the carotid sinus after 6‐hour‐incubation experiment. B, Protein expression of TRPV1 in the carotid sinus of rats after 8‐week‐experiment. C, Protein expressions of ASIC2 and TRPC5 in the carotid sinus of rats after 8‐week‐experiment. Mean±SE, n=8. \**P*\<0.05. ASIC2 indicates acid‐sensing ion channel 2; HA, hydroxylamine; SHR, spontaneously hypertensive rats; TRPC5, transient receptor potential channel subfamily C member 5; TRPV1, transient receptor potential cation channel subfamily V member 1; WKY, Wistar‐Kyoto rats.](JAH3-6-e004971-g005){#jah32216-fig-0005}

H~2~S Increased TRPV1 Protein Expression in Carotid Sinus {#jah32216-sec-0024}
---------------------------------------------------------

Protein expression of TRPV1 in the carotid sinus of SHRs and WKY rats was detected by western blotting after 8 weeks of experiment. Compared with WKY rats, TRPV1 protein expression in the carotid sinus of SHRs was reduced significantly. With the supplement of H~2~S, the expression of TRPV1 was increased noticeably; in contrast, TRPV1 protein expression was decreased significantly with the inhibition of H~2~S generation (Figure [5](#jah32216-fig-0005){ref-type="fig"}B).

With the administration of NaHS, protein expression of TRPV1 in the carotid sinus of WKY rats was unchanged; however, with the inhibition of H~2~S production, the expression of TRPV1 in the carotid sinus was reduced significantly in WKY rats (Figure [5](#jah32216-fig-0005){ref-type="fig"}B).

Considering that ASIC2 and TRPC5 were important constituents contributing to aortic baroreflex, we detected the change in expression of ASIC2 and TRPC5 in carotid sinus. Results showed that there was no difference in expression of ASIC2 and TRPC5 in carotid sinus tissues among the 6 groups (Figure [5](#jah32216-fig-0005){ref-type="fig"}C).

H~2~S Induced S‐Sulfhydration of TRPV1 in the Carotid Sinus {#jah32216-sec-0025}
-----------------------------------------------------------

To explore the mechanism for TRPV1 activation induced by H~2~S, we examined TRPV1 S‐sulfhydration in perfused carotid sinus of rats. The results showed that with the supplement of H~2~S, TRPV1 S‐sulfhydration was increased significantly in SHRs. Similarly, with the administration of NaHS, TRPV1 S‐sulfhydration was increased significantly in WKY rats (Figure [6](#jah32216-fig-0006){ref-type="fig"}).

![H~2~S induced S‐sulfhydration of TRPV1 in perfused carotid sinus of SHR and WKY. Mean±SE, n=8. \**P*\<0.05. HA indicates hydroxylamine; SHR, spontaneously hypertensive rats; SSH, S‐sulfhydration; TRPV1, transient receptor potential cation channel subfamily V member 1; WKY, Wistar‐Kyoto rats.](JAH3-6-e004971-g006){#jah32216-fig-0006}

Discussion {#jah32216-sec-0026}
==========

As the third gaseous molecule, H~2~S can be generated endogenously in the cardiovascular system and plays an important protective role in the regulation of blood pressure. H~2~S regulates blood pressure in multiple ways: relaxing vessels,[11](#jah32216-bib-0011){ref-type="ref"} inhibiting smooth muscle cell proliferation,[28](#jah32216-bib-0028){ref-type="ref"} alleviating vascular remodeling[29](#jah32216-bib-0029){ref-type="ref"} and so on. In the present study, we explored the effect of endogenous CBS/H~2~S in the carotid sinus in the development of hypertension and its possible mechanism. The data showed that the endogenous CBS/H~2~S pathway in the carotid sinus of SHRs was downregulated; however, CBS protein expression in the common carotid artery was not decreased. The different change might result from the fact that carotid sinus is a specialized structure of carotid artery. Unlike the common carotid artery, the carotid sinus is a major baroreception site in humans and most mammals and consists of many nerve endings expressing CBS. It was reported that CBS expression in the central nervous system in SHRs was downregulated compared with WKY rats.[30](#jah32216-bib-0030){ref-type="ref"} Consequently, we assumed that the downregulation of CBS expression in the carotid sinus of SHRs observed in our present study might be associated with the downregulation of CBS expression in the nerve terminals that are predominantly distributed in the carotid sinus. In addition, there was no difference in CSE expression in the carotid sinus between SHRs and WKY rats. The results suggested that an abnormal carotid sinus baroreceptor reflex in hypertension might be associated with the CBS/H~2~S pathway in the carotid sinus. With the supplement of H~2~S donor, the concentration of H~2~S in the plasma of SHRs was elevated and resulted in a decrease in blood pressure. After inhibition of endogenous H~2~S generation, the blood pressure of SHRs was further increased. In the same way, after inhibiting endogenous H~2~S generation of WKY rats, their blood pressure was raised. The results suggested that H~2~S played an important defensive role in the process of hypertension. The findings were consistent with previous studies[12](#jah32216-bib-0012){ref-type="ref"} that laid the foundation for further research on the mechanisms by which H~2~S regulates blood pressure.

Previous studies indicated that H~2~S participated in neuromodulation of arterial blood pressure.[31](#jah32216-bib-0031){ref-type="ref"} Carotid sinus baroreflex is the main route for neuromodulation of arterial blood pressure and can play an important role in hypertension development.[32](#jah32216-bib-0032){ref-type="ref"}, [33](#jah32216-bib-0033){ref-type="ref"}, [34](#jah32216-bib-0034){ref-type="ref"}, [35](#jah32216-bib-0035){ref-type="ref"} Carotid sinus baroreceptor sensitivity can be regulated by a variety of substances that come from the circulation or are released by cells in the carotid sinus region.[4](#jah32216-bib-0004){ref-type="ref"} Produced by vascular endothelial cells and neurons, H~2~S acts as a regulatory factor of autocrine and paracrine; however, how H~2~S participates in the regulation of the carotid sinus baroreceptor remains unclear. Previous studies have shown that H~2~S could facilitate carotid sinus baroreflex in a dose‐dependent manner under physiological condition[17](#jah32216-bib-0017){ref-type="ref"}; however, during the development of hypertension, it has not been clear whether carotid sinus baroreceptor sensitivity changes and whether H~2~S is involved in regulating sinus baroreceptor sensitivity. In our present study, carotid sinus baroreceptor sensitivity in hypertensive rats was decreased compared with that of normal rats and is associated with the downregulation of the endogenous CBS/H~2~S pathway in the carotid sinus. When we supplemented the H~2~S donor NaHS to the perfusate, carotid sinus baroreceptor sensitivity in hypertensive rats was significantly increased, whereas if given the CBS inhibitor HA, carotid sinus baroreceptor sensitivity was evidently decreased. The results suggested that during the development of hypertension, the endogenous CBS/H~2~S pathway played an important role in the regulation of carotid sinus BRS.

As an important member of the transient receptor potential family, TRPV1 plays an important role in thermal effect and introduction of pain.[20](#jah32216-bib-0020){ref-type="ref"}, [36](#jah32216-bib-0036){ref-type="ref"}, [37](#jah32216-bib-0037){ref-type="ref"}, [38](#jah32216-bib-0038){ref-type="ref"}, [39](#jah32216-bib-0039){ref-type="ref"} TRPV1, however, was reported to be expressed in the aortic arch and participated in the regulation of aortic baroreflex.[21](#jah32216-bib-0021){ref-type="ref"} In the present study, we found that TRPV1 was expressed in the carotid sinus and significantly reduced in SHRs. Moreover, the agonist or antagonist of TRPV1 could enhance or inhibit carotid sinus BRS, suggesting that carotid sinus TRPV1 played roles in blood pressure regulation. Furthermore, we found that the H~2~S donor could enhance TRPV1 expression, whereas HA could suppress it in carotid sinus tissue of SHRs. To explore whether TRPV1 mediated the effect of H~2~S on carotid sinus BRS, we observed the impact of TRPV1 antagonist capsazepine and its agonist capsaicin on H~2~S effect. The data showed that TRPV1 antagonist blunted the effect of H~2~S on carotid sinus baroreflex. In contrast, the TRPV1 agonist capsaicin enhanced the effect of H~2~S on carotid sinus baroreflex. These results suggested that TRPV1 mediated the regulation of carotid sinus BRS by H~2~S.

The thiol group is the important functional group of proteins, and the ‐S bond of H~2~S can combine with the thiol (‐SH) bond of cysteine residues to form persulfide (‐SSH). Previous studies have shown that H~2~S could make a series of reactions with sulfhydryl of cysteine residues on the protein to adjust the structure and function of the protein.[40](#jah32216-bib-0040){ref-type="ref"}, [41](#jah32216-bib-0041){ref-type="ref"}, [42](#jah32216-bib-0042){ref-type="ref"}, [43](#jah32216-bib-0043){ref-type="ref"} TRPV1 could be activated by H~2~O~2~, 4‐hydroxynonenal, or nitric oxide via posttranslational modification of cysteine‐free sulfhydryl groups in TRPV1.[44](#jah32216-bib-0044){ref-type="ref"}, [45](#jah32216-bib-0045){ref-type="ref"} We found that after giving H~2~S donor NaHS, S‐sulfhydration of TRPV1 was increased significantly in the carotid sinus of SHRs and WKY rats. The results provided a possible clue to examine the molecular mechanism by which H~2~S activated TRPV1.

ASIC2 and TRPC5 were important ion channels related to the regulation of aortic baroreceptor, and their defects or dysfunction would lead to the development of hypertension.[18](#jah32216-bib-0018){ref-type="ref"}, [19](#jah32216-bib-0019){ref-type="ref"} In our study, we found that protein expressions of ASIC2 and TRPC5 in the carotid sinus were not significantly different among different groups, indicating that these 2 ion channels might not be the target of CBS/H~2~S to regulate carotid sinus baroreflex.

In conclusion, our main findings were (1) that in the SHRs with high blood pressure, endogenous H~2~S and CBS in the carotid sinus were related to hypertension and (2) that carotid sinus TRPV1 might be a target of H~2~S in the regulation of carotid sinus baroreceptor sensitivity; H~2~S increased TRPV1 protein expression and activity to enhance carotid sinus baroreceptor sensitivity. This study revealed the molecular mechanism by which H~2~S regulated carotid sinus baroreceptor reflex sensitivity, which could have great potential for providing a new therapeutic strategy for the treatment of hypertension.
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